SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 5.09 |
Enterprise Value ($M) | 1.80 |
Book Value ($M) | 3.14 |
Book Value / Share | 0.45 |
Price / Book | 1.62 |
NCAV ($M) | 3.00 |
NCAV / Share | 0.43 |
Price / NCAV | 1.70 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.41 |
Return on Assets (ROA) | -1.00 |
Return on Equity (ROE) | -1.21 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 8.90 |
Current Ratio | 8.90 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 3.43 |
Assets | 3.58 |
Liabilities | 0.43 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.45 |
Operating Income | -4.75 |
Net Income | -4.62 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -3.15 |
Cash from Investing | -0.01 |
Cash from Financing | 1.34 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Kaufman Jonathan H | 21.00 | 9.00 | |
13D/A | Chancellor Michael B | 20.00 | 10.36 | |
13G/A | Gruber Michele | 5.50 | 3.30 | |
13G/A | Huang Leaf | 9.60 | 0.00 | |
13G | Sabby Management, Llc | 9.99 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
5,022 | 28,310 | 17.74 | |
959 | 15,472 | 6.20 | |
2,447 | 118 | 2,073.73 | |
400 | 265 | 150.94 | |
(click for more detail) |
Similar Companies | |
---|---|
LFVN – LifeVantage Corporation | LGVN – Longeveron Inc. |
LIFE – aTyr Pharma, Inc. | LIXT – Lixte Biotechnology Holdings, Inc. |
LPCN – Lipocine Inc. |
Financial data and stock pages provided by
Fintel.io